High‐resolution MALDI‐FT‐ICR MS imaging for the analysis of metabolites from formalin‐fixed, paraffin‐embedded clinical tissue samples
暂无分享,去创建一个
R. Langer | A. Feuchtinger | A. Walch | M. Aichler | A. Buck | B. Balluff | P. Kuppen | C. V. D. van de Velde | H. Zitzelsberger | M. Aubele | K. Janssen | N. Sun | G. Weirich | F. Erlmeier | A. Ly | K. Gorzolka | C. J. van de Velde
[1] Fulvio Magni,et al. A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues. , 2015, Molecular bioSystems.
[2] Peter J H Webborn,et al. Mass spectrometry imaging in drug development. , 2015, Analytical chemistry.
[3] Suming Chen,et al. MALDI-TOF MS imaging of metabolites with a N-(1-naphthyl) ethylenediamine dihydrochloride matrix and its application to colorectal cancer liver metastasis. , 2015, Analytical chemistry.
[4] Steven J. M. Jones,et al. Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.
[5] A. Walch,et al. High‐resolution metabolite imaging of light and dark treated retina using MALDI‐FTICR mass spectrometry , 2014, Proteomics.
[6] Noel W. Clarke,et al. Assessment of paraffin removal from prostate FFPE sections using transmission mode FTIR-FPA imaging , 2014 .
[7] B. Spengler,et al. Mass spectrometry imaging with high resolution in mass and space , 2013, Histochemistry and Cell Biology.
[8] Richard M Caprioli,et al. Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. , 2013, Chemical reviews.
[9] David S. Wishart,et al. HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..
[10] J. Asara,et al. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.
[11] R. Casadonte,et al. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry , 2011, Nature Protocols.
[12] J. Asara,et al. Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma , 2011, PloS one.
[13] R. Shah,et al. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics , 2011, Histopathology.
[14] Liam A. McDonnell,et al. Imaging mass spectrometry data reduction: Automated feature identification and extraction , 2010, Journal of the American Society for Mass Spectrometry.
[15] Kurt Zatloukal,et al. Proteomic analysis of PAXgene-fixed tissues. , 2010, Journal of proteome research.
[16] Zoltan Takats,et al. Histology by mass spectrometry: label-free tissue characterization obtained from high-accuracy bioanalytical imaging. , 2010, Angewandte Chemie.
[17] David S. Wishart,et al. MetaboAnalyst: a web server for metabolomic data analysis and interpretation , 2009, Nucleic Acids Res..
[18] D. Wishart. Proteomics and the Human Metabolome Project , 2007, Expert review of proteomics.
[19] Dante Mantini,et al. LIMPIC: a computational method for the separation of protein MALDI-TOF-MS signals from noise , 2007, BMC Bioinformatics.
[20] R. Abagyan,et al. METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.
[21] K. Bodger,et al. Detection of sulfated glycoproteins in intestinal metaplasia: a comparison of traditional mucin staining with immunohistochemistry for the sulfo-Lewisa carbohydrate epitope , 2003, Journal of clinical pathology.
[22] T. Irimura,et al. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma , 1998, Journal of Gastroenterology.
[23] F. André,et al. The carbohydrate and ester sulfate content of mucosal biopsies in health and in patients with duodenal ulcer. , 1974, Clinica chimica acta; international journal of clinical chemistry.
[24] N. G. Klyuyeva,et al. Biotherapy of Malignant Tumours , 1964 .
[25] J. Schrager. Sulphated Mucopolysaccharides of the Gastric Secretion , 1964, Nature.
[26] J. Brierley. Classification of Malignant Tumours , 1963, British medical journal.
[27] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[28] Nikhil Wagle,et al. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.
[29] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.